AIDS

1. LAURENCE J, Subramani K, Babii D, Walker B, et al
   SGLT2 inhibitor dapagliflozin attenuates HIV-associated cardiac fibrosis, steatosis and diastolic dysfunction in a mouse model via inhibition of TGFbeta signaling.
   AIDS. 2026;40:863-865.
   

   >> Share

   
   
2. BABBS G, Offiaeli K, Hughto JMW, Balkan E, et al
   Intersectional HIV disparities among transgender Medicare beneficiaries of color.
   AIDS. 2026;40:860-862.
   

   >> Share

   
   
3. CHAVEZ LA, Strathdee SA
   From systems that harm to systems that heal: ending HIV requires confronting gender-based violence across the life course.
   AIDS. 2026;40:857-859.
   

   >> Share

   
   
4. GIACOMELLI A, Gharakhanian S
   Applying rigorous real-world evidence methodology in HIV medicine: is more evidence needed with long-acting cabotegravir/rilpivirine?
   AIDS. 2026;40:854-856.
   

   >> Share

   
   
5. TSUKAMOTO T, Lurain K
   Driving in the right direction: new insights into genomic drivers of HIV-associated diffuse large B-cell lymphoma.
   AIDS. 2026;40:851-853.
   

   >> Share

   
   
6. PEPIN J
   The rise and fall of HIV in Kinshasa over a century.
   AIDS. 2026;40:703-714.
   

   >> Share

   
   

   
   AIDS Res Hum Retroviruses

7. ABDO M, Kunisaki KM, Morris A, Stosor V, et al
   Frailty, Physical Function Impairment, and Pulmonary Function in Aging Men With and Without HIV from the Multicenter AIDS Cohort Study.
   AIDS Res Hum Retroviruses. 2026 May 1:8892229261448283.
   

   >> Share

   
   

   
   Am J Epidemiol

8. DIEPSTRA K, Westreich D, Zivich PN, Chapola J, et al
   List randomization for prevalence estimation of sensitive behavioral data among women with HIV of reproductive age in Lilongwe, Malawi.
   Am J Epidemiol. 2026 May 1:kwag091. doi: 10.1093.
   

   >> Share

   
   

   
   BMJ

9. POOL E, Thompson M, Gibbs J, Shahmanesh M, et al
   HIV transmission cannot be stopped without equity.
   BMJ. 2026;393:s775.
   

   >> Share

   
   

   
   Clin Infect Dis

10. LAMB G, Pallett SJC, Charani E, Kanu EM, et al
    Assessment of the Prioritization of Diagnostics in National Action Plans for Antimicrobial Resistance.
    Clin Infect Dis. 2026 Apr 29:ciag020. doi: 10.1093.
    

    >> Share

    
    
11. SHERWOOD K, Zhang N, David H, Dekker A, et al
    Missed Opportunities for HIV and Syphilis Co-Testing in Emergency Departments.
    Clin Infect Dis. 2026 Apr 28:ciag289. doi: 10.1093.
    

    >> Share

    
    
12. FEITERNA-SPERLING C, Albers E, Rohr I, Weizsacker K, et al
    A case of delayed detection of vertical transmission of HIV-1 due to maternal therapy with long-acting injectable cabotegravir plus rilpivirine.
    Clin Infect Dis. 2026 Apr 28:ciag290. doi: 10.1093.
    

    >> Share

    
    
13. LANDOVITZ RJ, Fogel JM, Gao F, Hanscom B, et al
    Prospective HIV RNA screening with long-acting cabotegravir pre-exposure prophylaxis in HPTN 083.
    Clin Infect Dis. 2026 Apr 27:ciag285. doi: 10.1093.
    

    >> Share

    
    
14. CASILLAS SM, Chida A, Drobeniuc J, Sandul AL, et al
    Updated hepatitis D seroprevalence among HBsAg-positive persons aged >/=6 years in the United States, National Health and Nutrition Examination Survey, 2007?2018.
    Clin Infect Dis. 2026 Apr 25:ciag274. doi: 10.1093.
    

    >> Share

    
    
15. DORWARD J, Masombuka X, Lewis L, Pastellides C, et al
    Cardiovascular Disease Risk in Low- and MIddle-income countries: better data for better evidence.
    Clin Infect Dis. 2026 Apr 25:ciag280. doi: 10.1093.
    

    >> Share

    
    

    
    HIV Med

16. CLEMENTE T, Reali P, Lolatto R, Passini F, et al
    Effectiveness of switching regimen in people living with HIV and persistent low-level viraemia in the modern antiretroviral treatment era.
    HIV Med. 2026 Apr 29. doi: 10.1111/hiv.70251.
    

    >> Share

    
    
17. STENGAARD AR, Sullivan AK, Simoes D, Diderichsen J, et al
    An overview of consent requirements for HIV and viral hepatitis B and C testing in Europe.
    HIV Med. 2026 Apr 28. doi: 10.1111/hiv.70248.
    

    >> Share

    
    
18. MANYAAPELO T, Mpanza N, Mjilo T, Nxumalo S, et al
    Preventing weight gain for people living with HIV in rural KwaZulu-Natal, South Africa: A qualitative study of perspectives and strategies.
    HIV Med. 2026 Apr 28. doi: 10.1111/hiv.70216.
    

    >> Share

    
    
19. QIAN Z, Liu A, Yang J, Qin J, et al
    Bictegravir/emtricitabine/tenofovir alafenamide in viremic people with HIV harbouring nucleos(t)ide reverse transcriptase inhibitor resistance-associated mutations.
    HIV Med. 2026 Apr 28. doi: 10.1111/hiv.70249.
    

    >> Share

    
    
20. LI Y, Shan X, Feng T, Liu H, et al
    Worldwide changes in HIV-related stigma among people living with HIV: A cross-temporal meta-analysis and systematic review.
    HIV Med. 2026 Apr 27. doi: 10.1111/hiv.70246.
    

    >> Share

    
    

    
    J Acquir Immune Defic Syndr

21. LAMSAL R, Zhu W, Lampe MA, Huang YA, et al
    Trends in HIV Prenatal Testing among Commercially Insured Pregnant Women in the United States, 2011-2022.
    J Acquir Immune Defic Syndr. 2026 Apr 28. doi: 10.1097/QAI.0000000000003895.
    

    >> Share

    
    
22. MWEEBO K, Mwila A, Tinglof KF, Tenforde MW, et al
    Government to Government Model for HIV Service Delivery - An Approach for Country and Program Ownership in Four Provinces of Zambia.
    J Acquir Immune Defic Syndr. 2026 Apr 28. doi: 10.1097/QAI.0000000000003894.
    

    >> Share

    
    

    
    J Clin Invest

23. FILIPPIDIS P, Farhadian SF
    Smoldering in the sanctuary: HIV-associated brain injury in the ART era.
    J Clin Invest. 2026;136:e204831.
    

    >> Share

    
    

    
    J Infect Dis

24. WILBURN L, Bui HL, Akampurira P, Ddamba R, et al
    Schistosoma mansoni Infections Are Associated With Fecal Calprotectin Markers of Gut Inflammation After Accounting for HIV, Hepatitis B, and Malaria.
    J Infect Dis. 2026 Apr 29:jiag094. doi: 10.1093.
    

    >> Share

    
    
25. CHAUHAN L, Ghosh D, Ances B, Tassiopoulos K, et al
    CMV Immune Responses and Cognitive Impairment in People with HIV.
    J Infect Dis. 2026 Apr 28:jiag239. doi: 10.1093.
    

    >> Share

    
    
26. JIANG Y, Goetghebuer T, Embacher S, Thiriard A, et al
    Decreased persistence of maternal antibodies in infants who are HIV-exposed and uninfected.
    J Infect Dis. 2026 Apr 29:jiag236. doi: 10.1093.
    

    >> Share

    
    
27. EPLING BP, Mistry S, Grund B, Baker JV, et al
    Effect of Delayed Antiretroviral Therapy Initiation on Anti-CD4 Autoantibodies in Antiretroviral Therapy-Naive People With HIV.
    J Infect Dis. 2026 Apr 27:jiag235. doi: 10.1093.
    

    >> Share

    
    

    
    J Med Virol

28. MALONGA GA, Leducq V, Fauchois A, Moudiongui Mboungou Malanda D, et al
    KSHV Genome in Saliva, Whole Blood and Kaposi's Sarcoma Biopsy Specimens in Republic of Congo: Phylogenetic Analysis and an APOBEC3B Mutational Signature.
    J Med Virol. 2026;98:e70933.
    

    >> Share

    
    
29. FENG B, Liu L, Li M, Zhang J, et al
    Epidemiological Features and Temporal Trends of Five Common Sexually Transmitted Infections Excluding HIV, 1990-2021: Findings From the Global Burden of Disease Study.
    J Med Virol. 2026;98:e70937.
    

    >> Share

    
    

    
    J Virol

30. CHEN H-C
    Is the molecular microenvironment of the latent HIV reservoir predictable using deep learning approaches?
    J Virol. 2026 Apr 30:e0017526. doi: 10.1128/jvi.00175.
    

    >> Share

    
    
31. DA SILVA AMARAL S, Richetta C, Oualid L, Tu NQ, et al
    Effect of TAR hairpin stabilization on HIV-1 reverse transcription.
    J Virol. 2026 Apr 29:e0184025. doi: 10.1128/jvi.01840.
    

    >> Share

    
    

    
    Lancet

32. SHANKAR-HARI M, Ming D, Mendelson M, Rupali P, et al
    The Lancet Commission on Sepsis: transforming sepsis care and outcomes.
    Lancet. 2026 Apr 22:S0140-6736(26)00648-3. doi: 10.1016/S0140-6736(26)00648.
    

    >> Share

    
    

    
    MMWR Morb Mortal Wkly Rep

33. RAZ KM, Haddad MB, Althomsons SP, Cowan L, et al
    Large Tuberculosis Outbreaks - United States, 2017-2023.
    MMWR Morb Mortal Wkly Rep. 2026;75:205-210.
    

    >> Share

    
    

    
    N Engl J Med

34. YERLIKAYA S, Chirwa M, Ajide B, Castro MDM, et al
    Pulmonary Tuberculosis Detection with MiniDock MTB Using Swab Samples.
    N Engl J Med. 2026;394:1710-1722.
    

    >> Share

    
    

    
    Nature

35. GUENAGA J, Adori M, Bale S, Phulera S, et al
    Vaccination generates broadly cross-neutralizing antibodies to the HIV Env apex.
    Nature. 2026 Apr 29. doi: 10.1038/s41586-026-10429.
    

    >> Share

    
    

    
    Pediatr Rev

36. CERI A, Gultekin ND
    A Clinical Review of Congenital and Perinatal Infections: From Womb to Follow-Up.
    Pediatr Rev. 2026;47:241-250.
    

    >> Share

    
    

    
    PLoS Comput Biol

37. PAMORNCHAINAVAKUL N, Schroeder DC, VanderWaal K
    QoALa: A comprehensive workflow for viral quasispecies diversity comparison using long-read sequencing data.
    PLoS Comput Biol. 2026;22:e1014208.
    

    >> Share

    
    
38. MAC CANN R, Alalwan D, Saini G, Garcia Leon AA, et al
    Refining biomarker-based clustering of cardiovascular inflammatory phenotypes in HIV using Recursive Feature Addition: A comparative evaluation approach.
    PLoS Comput Biol. 2026;22:e1014209.
    

    >> Share

    
    

    
    PLoS One

39. ATSAMA-AMOUGOU M, Atsinkou SN, Bouba Y, Amadou H, et al
    Pre-analytical errors during HIV viral load (HIV-VL) and early infant diagnosis (EID) testing in Cameroon.
    PLoS One. 2026;21:e0324886.
    

    >> Share

    
    
40. DHANLIKA D, Haldar P, Nischal N, Wig N, et al
    Effectiveness of yoga therapy as an adjunct on mental health status, quality of life, and medication adherence among people living with HIV on antiretroviral therapy: A study protocol of a randomized controlled trial (ART YOGA).
    PLoS One. 2026;21:e0331992.
    

    >> Share

    
    
41. NABAYINDA J, Sensoy Bahar O, Namatovu P, Nabunya P, et al
    Acceptability of Suubi+Adherence intervention to improve ART adherence in Southern Uganda: A qualitative analysis.
    PLoS One. 2026;21:e0347112.
    

    >> Share

    
    
42. ELORREAGA OA, Qquellon J, Konda KA, Campos KE, et al
    Which are the most valued HIV pre-exposure prophylaxis attributes? A discrete choice experiment among sexual and gender minorities in Peru.
    PLoS One. 2026;21:e0346154.
    

    >> Share

    
    
43. MEKONEN EG
    Anemia among HIV?positive women in LMICs: Multilevel analysis of recent DHS survey.
    PLoS One. 2026;21:e0347752.
    

    >> Share

    
    

    
    PLoS Pathog

44. OMOLE TE, Nguyen HM, Marcinow A, Jahan N, et al
    Pre-Human Immunodeficiency Virus (HIV) infection Th17 CD4+ T cells as predictors of early HIV disease progression.
    PLoS Pathog. 2026;22:e1013852.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

45. HERBERT NG, Cromhout G, Bengu N, Fillis R, et al
    Antiretroviral therapy blocks natural selection on protective and disease-susceptible HLA-B alleles in HIV-1 infection.
    Proc Natl Acad Sci U S A. 2026;123:e2502683123.
    

    >> Share

    
    
46. KELENIS DP, Johnson JR, Sidoli S, Emery A, et al
    HIV-1 infection induces Vif-mediated SUMOylation of host RNA splicing factors important for proper viral RNA splicing.
    Proc Natl Acad Sci U S A. 2026;123:e2532659123.
    

    >> Share

    
    
47. HABIB R, Solieva SO, Lin ZJ, Ghosh S, et al
    Deep mining of the human antibody repertoire identifies frequent and genetically diverse CDRH3 topologies targetable by vaccination.
    Proc Natl Acad Sci U S A. 2026;123:e2532810123.
    

    >> Share

    
    

    
    Science

48. COHEN J
    How an HIV/AIDS tragedy spurred human evolution.
    Science. 2026;392:452-453.
    

    >> Share

    
    

    
    Vaccine

49. LEWIS K, Goulbourne D, Weiser-Schlesinger A, Miller C, et al
    Motivating factors among LGBTQ+ individuals for the uptake of a forthcoming HIV vaccine: recommendations for enhancing preparedness.
    Vaccine. 2026;82:128597.
    

    >> Share

    
    
50. ADJEI IA, Mupambireyi Z, White SA, Matsikire E, et al
    Prevalence of group B Streptococcus colonization in pregnant women and serotype specific immunity among mother-newborns dyads in Ghana and Zimbabwe.
    Vaccine. 2026;82:128626.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share